REYZDIVI
Live / Allowed — Notice of allowance issued (as of 10 Mar 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 03 Apr 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 99119116
- Mark type
- Stylized text
- Filed
- 03 Apr 2025
- Published for opposition
- 13 Jan 2026
- Attorney of record
- Heather A. McDonald
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, skin disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes; pharmaceutical preparations, namely, anti-infective preparations, medicated dermatological preparations and smoking cessation preparations; vaccines for human use.
Owner
- Pfizer Inc., New York, NY, US
- Pfizer Inc., New York, NY, US
Prosecution history
- 10 Mar 2026 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 13 Jan 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 13 Jan 2026 — PUBLISHED FOR OPPOSITION
- 07 Jan 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 12 Dec 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 14 Nov 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 14 Nov 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 14 Nov 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 28 Oct 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 28 Oct 2025 — NON-FINAL ACTION E-MAILED
- 28 Oct 2025 — NON-FINAL ACTION WRITTEN
- 22 Oct 2025 — ASSIGNED TO EXAMINER
- 21 Oct 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 03 Apr 2025 — APPLICATION FILING RECEIPT MAILED
- 03 Apr 2025 — NEW APPLICATION ENTERED